论文信息 - A Phase 1, Open-Label Study of MGD013, a Bispecific DART® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - 字舞流文

A Phase 1, Open-Label Study of MGD013, a Bispecific DART® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

P. Moore | A. Asch | Hua Li | B. Sumrow | J. Muth | Jichao Sun | M. Długosz-Danecka | S. Bahadur | A. Weickhardt | N. Hamad | H. Pylypenko | Francine Z Chen | P. Kaminker | Jie Wang | S. Ulahannan | M. Tomaszewska-Kiecana | Xiaoyu Zhang | Janine Koucheki